TrialCancer medicine2025

Multi-Institutional Phase II Study on the Efficacy and Safety of Dynamic Tumor-Tracking, Moderately Hypofractionated Intensity-Modulated Radiotherapy in Patients With Locally Advanced Pancreatic Cancer.

Michio Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.